tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Lifeward Secures $3M Promissory Note with Oramed

Story Highlights
  • Lifeward Ltd. secured a $3.0 million loan from Oramed Ltd. on November 14, 2025.
  • The loan supports Lifeward’s operations amid record Medicare placements and efficiency gains.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Lifeward Secures $3M Promissory Note with Oramed

TipRanks Black Friday Sale

Lifeward ( (LFWD) ) has provided an announcement.

On November 14, 2025, Lifeward Ltd. entered into a $3.0 million Secured Promissory Note with Oramed Ltd., providing additional capital support for its operations. The loan, which matures on May 14, 2026, is secured by a lien on Lifeward’s cash and carries a 15% annual interest rate. The agreement includes provisions for conversion into Lifeward’s ordinary shares and limits Oramed’s ownership to 4.99%. This financial move follows Lifeward’s record quarter for Medicare placements, improved operational efficiency, and strategic expansions, positioning the company for continued growth and enhanced patient access.

The most recent analyst rating on (LFWD) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Lifeward stock, see the LFWD Stock Forecast page.

Spark’s Take on LFWD Stock

According to Spark, TipRanks’ AI Analyst, LFWD is a Neutral.

Lifeward’s stock score is influenced by strong revenue growth but substantial risks due to profitability challenges, negative cash flows, and unattractive valuation. Technical indicators and recent corporate events further underscore the cautious outlook, despite strategic initiatives. Key risks involve financial instability and operational inefficiencies.

To see Spark’s full report on LFWD stock, click here.

More about Lifeward

Lifeward Ltd. is a global leader in innovative medical technology focused on transforming the lives of individuals with physical limitations or disabilities. The company designs, develops, and commercializes solutions for physical rehabilitation and recovery, offering products such as the ReWalk Exoskeleton, AlterG Anti-Gravity system, ReStore Exo-Suit, and MyoCycle FES System. Founded in 2001, Lifeward operates in the United States, Israel, and Germany.

Average Trading Volume: 331,108

Technical Sentiment Signal: Sell

Current Market Cap: $8.43M

See more insights into LFWD stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1